CCR3 and cancer: Indeed, there were significantly higher frequencies of CCR3+ NK cells in the circulation of OAC patients relative to non-cancer controls; non-cancer versus OAC (2.983% vs. 11.00%, p = 0.02) (Fig. 5f).